Temporal trends of outcomes of neutropenic patients with ARDS enrolled in therapeutic clinical trials

David R. Price; Katherine L. Hoffman; Elizabeth Sanchez; Augustine M.K. Choi; Ilias I. Siempos

doi:10.1007/s00134-020-06263-4

Temporal trends of outcomes of neutropenic patients with ARDS enrolled in therapeutic clinical trials

David R. Price, Katherine L. Hoffman, Elizabeth Sanchez, Augustine M.K. Choi, Ilias I. Siempos

Research output: Contribution to journal › Letter › peer-review

Original language	English (US)
Pages (from-to)	122-123
Number of pages	2
Journal	Intensive Care Medicine
Volume	47
Issue number	1
DOIs	https://doi.org/10.1007/s00134-020-06263-4
State	Published - Jan 2021

ASJC Scopus subject areas

Critical Care and Intensive Care Medicine

Access to Document

10.1007/s00134-020-06263-4

Cite this

@article{837a0cb9c408448c9430fdd1f83a3c23,

title = "Temporal trends of outcomes of neutropenic patients with ARDS enrolled in therapeutic clinical trials",

author = "Price, {David R.} and Hoffman, {Katherine L.} and Elizabeth Sanchez and Choi, {Augustine M.K.} and Siempos, {Ilias I.}",

note = "Funding Information: This study was prepared using ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS research materials obtained from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordination Center (BioLINCC). The manuscript does not necessarily reflect the opinions or views of the researchers who performed these trials or the NHLBI. The authors acknowledge the incredible work by the ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS researchers, without which this study would not have been possible. This study was funded by grants from NIH (US) (T32HL134629-01A1), Stony Wold-Herbert Fund (US) and Hellenic Thoracic Society (GR) (2019). Funding Information: This study was prepared using ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS research materials obtained from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordination Center (BioLINCC). The manuscript does not necessarily reflect the opinions or views of the researchers who performed these trials or the NHLBI. The authors acknowledge the incredible work by the ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS researchers, without which this study would not have been possible.?This?study was funded by grants from NIH (US)?(T32HL134629-01A1), Stony Wold-Herbert Fund (US)?and?Hellenic Thoracic Society (GR)?(2019).",

year = "2021",

month = jan,

doi = "10.1007/s00134-020-06263-4",

language = "English (US)",

volume = "47",

pages = "122--123",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer Verlag",

number = "1",

}

TY - JOUR

T1 - Temporal trends of outcomes of neutropenic patients with ARDS enrolled in therapeutic clinical trials

AU - Price, David R.

AU - Hoffman, Katherine L.

AU - Sanchez, Elizabeth

AU - Choi, Augustine M.K.

AU - Siempos, Ilias I.

N1 - Funding Information: This study was prepared using ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS research materials obtained from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordination Center (BioLINCC). The manuscript does not necessarily reflect the opinions or views of the researchers who performed these trials or the NHLBI. The authors acknowledge the incredible work by the ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS researchers, without which this study would not have been possible. This study was funded by grants from NIH (US) (T32HL134629-01A1), Stony Wold-Herbert Fund (US) and Hellenic Thoracic Society (GR) (2019). Funding Information: This study was prepared using ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS research materials obtained from the National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Biologic Specimen and Data Repository Information Coordination Center (BioLINCC). The manuscript does not necessarily reflect the opinions or views of the researchers who performed these trials or the NHLBI. The authors acknowledge the incredible work by the ARMA, ALVEOLI, FACTT, ALTA, EDEN, and SAILS researchers, without which this study would not have been possible.?This?study was funded by grants from NIH (US)?(T32HL134629-01A1), Stony Wold-Herbert Fund (US)?and?Hellenic Thoracic Society (GR)?(2019).

PY - 2021/1

Y1 - 2021/1

UR - http://www.scopus.com/inward/record.url?scp=85092382352&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092382352&partnerID=8YFLogxK

U2 - 10.1007/s00134-020-06263-4

DO - 10.1007/s00134-020-06263-4

M3 - Letter

C2 - 33034690

AN - SCOPUS:85092382352

SN - 0342-4642

VL - 47

SP - 122

EP - 123

JO - Intensive Care Medicine

JF - Intensive Care Medicine

IS - 1

ER -

Temporal trends of outcomes of neutropenic patients with ARDS enrolled in therapeutic clinical trials

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this